Goldman Sachs Upgrades Vertex Pharmaceuticals To Buy By: Benzinga via Benzinga September 08, 2014 at 07:59 AM EDT Analysts at Goldman Sachs upgraded Vertex Pharmaceuticals (NASDAQ: VRTX) from Neutral to Buy. The target price for Vertex ... Read More >> Related Stocks: Vertex Pharmaceuticals